We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+24.95%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.44B
AUM Growth
-$42.2M
Cap. Flow
-$133M
Cap. Flow %
-9.26%
Top 10 Hldgs %
29.23%
Holding
202
New
26
Increased
19
Reduced
11
Closed
39

Sector Composition

Rank Sector Weight
1 Healthcare 12.86%
2 Consumer Discretionary 12.47%
3 Financials 11.09%
4 Industrials 7.54%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETW
101
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.01B
$1.81M 0.13%
221,120
+58,095
+36% +$461K
HIFS icon
102
Hingham Institution for Saving
HIFS
$624M
$1.78M 0.12%
10,205
DECAW
103
DELISTED
Denali Capital Acquisition Corp. Warrant
DECAW
$1.71M 0.12%
195,103
-3,062
-2% -$145
CENTA icon
104
Central Garden & Pet Co Class A
CENTA
$2.43B
$1.65M 0.11%
+44,655
New +$1.58M
WNEB icon
105
Western New England Bancorp
WNEB
$260M
$1.64M 0.11%
213,626
OPEN icon
106
Opendoor
OPEN
$3.54B
$1.63M 0.11%
+555,183
New +$1.73M
CPBI icon
107
Central Plains Bancshares
CPBI
$83M
$1.62M 0.11%
158,218
NECB icon
108
Northeast Community Bancorp
NECB
$373M
$1.59M 0.11%
100,963
SRBK icon
109
SR Bancorp
SRBK
$144M
$1.58M 0.11%
167,422
NBBK icon
110
NB Bancorp
NBBK
$993M
$1.57M 0.11%
+115,270
New +$1.61M
WMPN
111
DELISTED
William Penn Bancorporation Common Stock
WMPN
$1.55M 0.11%
125,533
PDLB icon
112
Ponce Financial Group
PDLB
$486M
$1.55M 0.11%
174,092
IBACU
113
DELISTED
IB Acquisition Corp. Unit
IBACU
$1.25M 0.09%
+125,000
New +$1.25M
VSACW
114
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$1.1M 0.08%
98,863
EVE
115
DELISTED
EVe Mobility Acquisition Corp
EVE
$1.06M 0.07%
97,260
NPABW
116
DELISTED
New Providence Acquisition Corp. II Warrant
NPABW
$1.04M 0.07%
96,543
NOVVW
117
DELISTED
Nova Vision Acquisition Corp. Warrant
NOVVW
$1.01M 0.07%
176,051
ECDAW
118
DELISTED
ECD Automotive Design Warrant
ECDAW
$929K 0.06%
988,810
UCFIW
119
CN Healthy Food Tech Group Warrant
UCFIW
$784K 0.05%
+78,592
New +$2.57K
BHAC
120
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$566K 0.04%
53,908
ONMDW icon
121
OneMedNet Corp Warrant
ONMDW
$770K
$355K 0.02%
500,000
CSLMR
122
DELISTED
CSLM Acquisition Corp. Right
CSLMR
$351K 0.02%
1,950,000
CDAQ
123
DELISTED
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
$287K 0.02%
+26,837
New +$286K
TENKR
124
DELISTED
TenX Keane Acquisition Right
TENKR
$274K 0.02%
1,500,000
GODNR
125
DELISTED
Golden Star Acquisition Corporation Rights
GODNR
$271K 0.02%
1,092,766

Similar funds

Mangrove Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Mangrove Partners held 202 positions worth $1.44B, down 2.8% from $1.48B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Mangrove Partners withdrew a net $133M in Q1 2024, closing 39 positions and reducing 11 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $64.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.6% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Mangrove Partners opened a new position in Teva Pharmaceuticals worth $39M.

  • Mangrove Partners's largest Q1 2024 buy was Teva Pharmaceuticals: 2,762,154 shares worth $39M.
  • Mangrove Partners added most to US Steel in Q1 2024, an estimated $34.6M increase.
  • Mangrove Partners's biggest Q1 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $62.7M.
  • Mangrove Partners fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $64.7M.
  • Mangrove Partners's ten largest holdings make up 29% of its $1.44B portfolio in Q1 2024.
  • Mangrove Partners opened 26 new positions and closed 39 in Q1 2024.
  • Mangrove Partners's portfolio value fell 2.8% quarter-over-quarter to $1.44B.

Based on Mangrove Partners's 13F filing for Q1 2024, filed 15 May 2024.